logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
25/08/2025
Concept stocks of innovative drugs on A-shares are oscillating upwards, with Yuandong Biological and Kangtai Biological rising by more than 10%, while Celling Medical, Shu Tai Shen, Anglikang, and Zhifei Biological also followed the uptrend.
Latest
1 m ago
Haidilao: In the first half of the year, the revenue was 20.7 billion yuan, estimated at 20.7 billion yuan. Net profit was 1.76 billion yuan, estimated at 2.2 billion yuan.
1 m ago
Haidilao: Net profit in the first half of the year was 1.76 billion Chinese yuan, estimated to be 2.2 billion Chinese yuan.
1 m ago
Zhejiang Yongqiang (002489.SZ) released its financial results for the first half of the year, with a net profit attributable to shareholders of 513 million yuan, an increase of 0.88%.
1 m ago
The Indian Sensex index closed up 0.4% at 81635.91 points.
2 m ago
Jinji Holdings: Net profit in the first half of 2025 is approximately 149 million US dollars, a year-on-year increase of 68.8%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.